D. Vergnaghi et al., A use of a neural network to evaluate contrast enhancement curves in breast magnetic resonance images, J DIGIT IM, 14(2), 2001, pp. 58-59
For the diagnosis of breast cancer using magnetic resonance imaging (MRI),
one of the most important parameters is the analysis of contrast enhancemen
t. A three-dimensional MR sequence is applied before and five times after b
olus injection of paramagnetic contrast medium (Gd-DTPA). The dynamics of a
bsorption are described by a time/intensity enhancement curve, which report
s the mean intensity of the MR signal in a small region of interest (ROI) f
or about 8 minutes after contrast injection. The aim of our study was to us
e an artificial neural network to automatically classify the enhancement cu
rves as "benign" or "malignant." We used a classic feed-forward back-propag
ation neural network, with three layers: five input nodes, two hidden nodes
, and one output node. The network has been trained with 26 pathologic curv
es (10 invasive carcinoma [K], two carcinoma-in-situ [DCIS], and 14 benign
lesion [BI). The trained network has been tested with 58 curves (36 K, one
DCIS, 21 B). The network was able to correctly identify the test curves wit
h a sensitivity of 76% and a specificity of 90%. For comparison, the same s
et of curves was analyzed separately by two radiologists (a breast MR exper
t and a resident radiologist). The first correctly interpreted the curves w
ith a sensitivity of 76% and a specificity of 90%, while the second scored
59% for sensitivity and 90% for specificity. These results demonstrate that
a trained neural network recognizes the pathologic curves at least as well
as an expert radiologist. This algorithm can help the radiologist attain r
apid and affordable screening of a large number of ROIs. A complete automat
ic computer-aided diagnosis support system should find a number of potentia
lly interesting ROIs and automatically analyze the enhancement curves for e
ach ROI by neural networks, reporting to the radiologist only the potential
ly pathologic ROIs for a more accurate, manual, repeated evaluation. Copyri
ght (C) 2001 by W.B. Saunders Company.